Oct 25 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- TOTAL REVENUE GUIDANCE FOR FY23 OF NZ$62-64 MILLION
- FY23 NORMALISED EBITDA EXPECTED TO BE APPROXIMATELY BREAKEVEN
- H1 FY23 PRODUCT REVENUE (UNAUDITED) GREW 44% TO NZ$28.8 MILLION
Oct 25 (Reuters) - Aroa Biosurgery Ltd (ARX) : TOTAL REVENUE...
Add to My Watchlist
What is My Watchlist?